Tabuniag, Ancharly, JR.. C.
HRN: 24-36-36 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2024
AMPICILLIN 500MG (VIAL)
04/27/2024
05/03/2024
IV
285mg
Q6h
Urinary Tract Infection
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes